Signal active
Contact Information
Social
Primary Organization
2011
11-50
Biotechnology, Medical, Health Diagnostics
Bio
XuemingQian has over eighteen years of industrial antibody discovery and development experience. Before starting MABSPACE, XuemingQian was Senior VP and Head of R&D of Shenogen Pharma Group from 2010 and 2012; a Beijing-based biopharma company developing ER-a36 based anti-cancer therapies. From 1997 and 2010 XuemingQian worked at Amgen as principal scientist and led multiple project teams to discover novel antibody therapeutics for the autoimmune diseases and metabolic disorders (bone and kidney). He is the leading inventor of multiple antibody patents.XuemingQian graduated from Fudan University and completed his graduate studies at Columbia University and Albany Medical Center. He is a member of Antibody Society, International Society of Nephrology and BayHelix,a member of National Thousand Talents program.
Location
Suzhou, Jiangsu, China, Asia
Jobs history
1
Transcenta
Co-Founder & CEO
2019 - Current
Educations
1
N/A
Profile Resume
Xueming Qian is the Founder, Chairman and Chief Executive Officer at MabSpace Biosciences, based in Asia. With a background in Biotechnology, Xueming Qian has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.